US Stock MarketDetailed Quotes

SLRX Salarius Pharmaceuticals

Watchlist

2.6900
+0.0700+2.67%

Close Jan 17 16:00 ET

2.7264
+0.0364+1.35%

Post 20:01 ET

3.88MMarket Cap-0.52P/E (TTM)

Salarius Pharmaceuticals Stock Forum

Tiggerpepper

Jan 14 09:38

😡

$Salarius Pharmaceuticals (SLRX.US)$

cuteju928

Jan 14 09:33

😭😭

$Salarius Pharmaceuticals (SLRX.US)$

r33duk

Jan 14 07:00

$Soligenix (SNGX.US)$
🚀🚀🚀
Can this stock run like $Phio Pharmaceuticals (PHIO.US)$ and $Salarius Pharmaceuticals (SLRX.US)$ ?

Jaguar8

Jan 13 20:08

🔵 Watchlist JANUARY 14,2025, Tuesday. NFA. DO NOT ENTER without buy momentum.

NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you d...

李飞Allyssa : Doctor, can you please take a look at LAES?

Report
Reply

Cancel Reply
Jaguar8 OP 李飞Allyssa : Sorry I forgot haha WKEY and LAES are together

Report
Reply

Cancel Reply
李飞Allyssa : Hope it rebounds tomorrow, thank you very much for your efforts

Report
Reply

Cancel Reply
152390662 : May I ask where did you see the announcement for $LeddarTech (LDTC.US)$

Report
Reply

Cancel Reply
Jaguar8 OP 152390662 : QUEBEC CITY, Canada, Jan. 13, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-based low-level sensor fusion and perception software technology, LeddarVision, today announced it has wrapped up its presence at the 2025 Consumer Electronics Show (CES) and achieved key strategic milestones. The culmination of the event demonstrates that the company is poised to deliver exceptional value to its customers.
Driving Innovation Through Strategic Partnerships
With the successful CES 2025 demonstration of LeddarVision Surround (LVS-2+) software utilizing Texas Instruments (“TI”) TDA4VH-Q1 processor, LeddarTech has now received the second advanced royalty payment of US$ 3 million as part of its licensing agreement. This partnership, announced in early December 2024, aims to capitalize on the integration of LeddarTech’s groundbreaking LeddarVision software into TI’s scalable portfolio of processors to create a comprehensive platform for advanced driver assistance systems (ADAS) and autonomous driving (AD) markets. The collaboration signifies a pivotal step forward in delivering cutting-edge solutions to automotive OEMs and Tier 1 suppliers, underscoring LeddarTech’s commitment to innovation and leadership.
Customer and Partner Enthusiasm at CES 2025
At CES 2025 in Las Vegas, LeddarTech showcased its LeddarVision Surround-View (LVS-2+), a state-of-the-art software stack tailored for L2/L2+ highway and city ADAS applications. This breakthrough technology addresses critical challenges the automotive industry faces, setting new benchmarks in safety and performance and enabling automotive manufacturers to cost-effectively meet 5-star NCAP 2025/GSR 2022 requirements.

Report
Reply

Cancel Reply

View more comments...

Andre MUGARURA552

Jan 13 15:12

$Salarius Pharmaceuticals (SLRX.US)$ I told you guys to sell and short this penny stock at market close or near it!!! By tomorrow it will be down some more!!! I will close my position tomorrow at market open and buy the most trending stocks for 45 minutes or until I reach maximum return for the risk, then sell it at around 10 am or after 9:40 am, then short those later that evening!!